LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 95.66 | 27.76 | 8596 | 6712 | 1.2806 | 1.0635 | MN20160318_Q01 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 95.66 | 27.76 | 4159 | 6712 | 0.6196 | 0.8827 | MN20160318_Q01 | M13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 95.66 | 27.76 | 11191 | 6712 | 1.6672 | 1.1334 | MN20160318_Q01 | M13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 1.95 | 27.76 | 620 | 225 | 2.7538 | 1.7971 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 1.95 | 27.76 | 737 | 225 | 3.2735 | 1.9619 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 3.66 | 27.76 | 663 | 283 | 2.3351 | 1.5753 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 3.66 | 27.76 | 815 | 283 | 2.8704 | 1.7387 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 5.36 | 27.76 | 3 | 320 | 0.0094 | -0.4677 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 5.36 | 27.76 | 706 | 320 | 2.2038 | 1.5020 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 5.36 | 27.76 | 918 | 320 | 2.8656 | 1.6953 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 7.06 | 27.76 | 8 | 360 | 0.0222 | -0.2858 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 7.06 | 27.76 | 815 | 360 | 2.2639 | 1.4947 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 7.06 | 27.76 | 985 | 360 | 2.7361 | 1.6259 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 8.76 | 27.76 | 36 | 401 | 0.0897 | 0.0698 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 8.76 | 27.76 | 864 | 401 | 2.1538 | 1.4407 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 8.76 | 27.76 | 1 | 401 | 0.0025 | -0.5779 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 8.76 | 27.76 | 1070 | 401 | 2.6674 | 1.5800 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 10.46 | 27.76 | 96 | 438 | 0.2189 | 0.3656 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 10.46 | 27.76 | 933 | 438 | 2.1270 | 1.4174 | MN20160318_Q01 | C03 |